StockData
PAVmed Inc. logo

PAVmed Inc. (PAVM) stock

PAVMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$1.14−0.06 (-5.42%)

Close on Nov 20, 2026Market cap $9.08MP/E –Yield –

PAVmed free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

PAVmed's free cash flow for the twelve months ending Jun 30, 2026 was -$7.78M. For fiscal 2025 it was -$5.24M. The highest annual figure on record is -$4.48M in fiscal 2016.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$5.24M–
FY2024Dec 31, 2024-$33.61M–
FY2023Dec 31, 2023-$52.28M–
FY2022Dec 31, 2022-$72.53M–
FY2021Dec 31, 2021-$42.06M–
FY2020Dec 31, 2020-$21.97M–
FY2019Dec 31, 2019-$13.38M–
FY2018Dec 31, 2018-$8.81M–
FY2017Dec 31, 2017-$6.61M–
FY2016Dec 31, 2016-$4.48M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$2.68M–
Q1 FY2026Mar 31, 2026-$2.64M–
Q4 FY2025Dec 31, 2025-$1.57M-1838.9%
Q3 FY2025Sep 30, 2025-$899.00K–
Q2 FY2025Jun 30, 2025-$1.19M–
Q1 FY2025Mar 31, 2025-$1.59M–
Q4 FY2024Dec 31, 2024$90.00K–
Q3 FY2024Sep 30, 2024-$8.89M–
Q2 FY2024Jun 30, 2024-$11.66M–
Q1 FY2024Mar 31, 2024-$13.15M–
Q4 FY2023Dec 31, 2023-$12.06M–
Q3 FY2023Sep 30, 2023-$11.11M–
Q2 FY2023Jun 30, 2023-$12.73M–
Q1 FY2023Mar 31, 2023-$16.39M–
Q4 FY2022Dec 31, 2022-$17.12M–
Q3 FY2022Sep 30, 2022-$19.66M–
Q2 FY2022Jun 30, 2022-$22.91M–
Q1 FY2022Mar 31, 2022-$12.84M–
Q4 FY2021Dec 31, 2021-$18.05M–
Q3 FY2021Sep 30, 2021-$8.05M–
Q2 FY2021Jun 30, 2021-$6.75M–
Q1 FY2021Mar 31, 2021-$9.20M–
Q4 FY2020Dec 31, 2020-$6.74M–
Q3 FY2020Sep 30, 2020-$5.84M–
Q2 FY2020Jun 30, 2020-$5.60M–
Q1 FY2020Mar 31, 2020-$3.79M–
Q4 FY2019Dec 31, 2019-$4.09M–
Q3 FY2019Sep 30, 2019-$2.88M–
Q2 FY2019Jun 30, 2019-$2.54M–
Q1 FY2019Mar 31, 2019-$3.87M–
Q4 FY2018Dec 31, 2018-$3.02M–
Q4 FY2017Dec 31, 2017-$1.59M–
Q3 FY2017Sep 30, 2017-$2.37M–
Q2 FY2017Jun 30, 2017-$823.60K–
Q1 FY2017Mar 31, 2017-$1.83M–
Q4 FY2016Dec 31, 2016-$1.20M–
Q3 FY2016Sep 30, 2016-$1.23M–

More PAVmed figures

See a number that looks wrong?